The Fallopian Tube’s Hidden Secret: Serous Tubal Intraepithelial Carcinoma and its Revolution in Ovarian Cancer - A Systematic Review

BACKGROUND: The understanding of ovarian cancer pathogenesis has been fundamentally revised. High-grade serous carcinoma (HGSC), the commonest lethal subtype, is now known to mostly originate from serous tubal intraepithelial carcinoma (STIC). This finding came with significant implications for prevention, diagnosis, and clinical management of this condition. OBJECTIVES: This systematic review put together the current evidence on STIC, particularly focusing on its role in ovarian carcinogenesis, the consequent choice of opportunistic salpingectomy (OS) for prevention, and the persistent clinical/pathological challenges in its diagnosis. METHODS: A systematic search of PubMed/MEDLINE and Embase was conducted for studies published between 2016 and 2024. Search terms included "serous tubal intraepithelial carcinoma," "STIC," "ovarian cancer origin," "opportunistic salpingectomy," and "fallopian tube precursor." Studies were screened for relevance to the pathological criteria, clinical management, and preventive strategies related to STIC. RESULTS: The fallopian tube fimbria as the site of origin for most of HGSCs. OS is emerging as a effective prevention strategy, with data showing a significant reduction in ovarian malignancy incidence. Pathologically, the diagnosis of STIC relies on a combination of severe morphological atypia and an aberrant p53 immunohistochemical pattern. The management of an incidental STIC, particularly in risk-reducing surgery, is controversial due to uncertainties about its metastatic potential. CONCLUSION: STIC discovery has significantly changed ovarian cancer prevention, making opportunistic salpingectomy a new standard of care. Diagnostic challenges and a lack of consensus on the clinical management of isolated STIC lesions reveal critical areas for future research.